Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Statement re Possible Offer

9 Jun 2025 07:00

RNS Number : 9026L
Revolution Beauty Group PLC
09 June 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR. 

FOR IMMEDIATE RELEASE

 

9 June 2025

Revolution Beauty Group Plc

("Revolution Beauty" or the "Company")

Statement regarding possible offer

Revolution Beauty notes the recent press speculation regarding the interest of Frasers Group plc ("Frasers") in Revolution Beauty and confirms that Frasers is one of a number of parties conducting due diligence as part of the Formal Sale Process announced on 21 May 2025. There can be no certainty that Frasers' interest will result in a firm offer for the Company.

Further updates will be provided if and when appropriate. Shareholders are advised to take no action at this time.

The person responsible for arranging this announcement on behalf of the Company is Neil Catto, Chief Financial Officer.

For further information, please contact:

Revolution Beauty Group Plc

 

 

Colin Henry (Interim CEO) / Neil Catto (CFO)

 

+44 (0)20 3805 4822 (Via Headland Consultancy)

 

 

 

Panmure Liberum Limited (Sole Financial Adviser, NOMAD and Joint Broker, Sole Rule 3 Adviser)

 

+44 (0)20 3100 2222

Investment Banking: Bidhi Bhoma / Dru Danford / Edward Thomas / John More

M&A: Tim Medak

 

 

 

 

 

Zeus Capital

 

+44 (0)20 3100 2222

Dominic King / Jordan Warburton

 

 

 

 

Headland Consultancy (Public Relations)

 

+44 (0)20 3805 4822

Matt Denham / Antonia Pollock

 

 

Notice related to financial advisers

Panmure Liberum Limited ("Panmure Liberum"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Revolution Beauty and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Revolution Beauty for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

Zeus Capital Limited, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Revolution Beauty and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Revolution Beauty for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

Disclosure requirements of the Takeover Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Website publication

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) on the Company's website at https://Revolution Beautyplc.com/regulatory-news/ promptly and by no later than 12 noon (London time) on the business day following the date of this announcement. The content of this website is not incorporated in, and does not form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDMZGGVFRVGKZM
Date   Source Headline
7th Mar 20232:00 pmRNSRevised deferred consideration for Medichem
21st Feb 20237:00 amRNSUpdate on FY22 Audit
13th Jan 20237:00 amRNSOutcome of Independent Investigation
16th Dec 20222:35 pmRNSDirectorate Change
28th Nov 20222:24 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSAppointment of CEO
25th Nov 20224:27 pmRNSTR-1: Standard notification of major holdings
9th Nov 20229:05 amRNSDirectorate Change
27th Oct 20225:30 pmRNSSuspended Companies Notice – Deletions
14th Oct 20227:00 amRNSUpdate on Independent Investigation
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
7th Sep 20227:00 amRNSTR-1: Standard notification of major holdings
1st Sep 20227:30 amRNSSuspension - Revolution Beauty Group plc
30th Aug 20227:00 amRNSUpdate on Publication of Final Results
19th Aug 20222:30 pmRNSFurther update on the Group’s audit
17th Aug 20226:20 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:15 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:00 pmRNSTR-1: Standard notification of major holdings
17th Aug 20227:05 amRNSStrategic Investment in Revolution Beauty Group
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
12th Aug 20221:55 pmRNSTR-1: Standard notification of major holdings
11th Aug 20224:41 pmRNSSecond Price Monitoring Extn
11th Aug 20224:35 pmRNSPrice Monitoring Extension
11th Aug 202211:05 amRNSUpdate on the Group’s audit
11th Aug 202210:10 amRNSTR-1: Standard notification of major holdings
5th Aug 20221:20 pmRNSTR-1: Standard notification of major holdings
3rd Aug 20223:45 pmRNSTR-1 Standard notification of major holdings
2nd Aug 20227:00 amRNSTrading update and change to results date
30th Jun 20227:00 amRNSCorporate Broker Appointment and Notice of Results
17th Jun 20227:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
12th May 20227:00 amRNSAppointment of Chief Financial Officer
11th May 202211:40 amRNSHolding(s) in Company
6th May 20227:00 amRNSFull Year Trading Update
25th Feb 20227:00 amRNSAcquisition
23rd Feb 20225:50 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSTrading Update
24th Nov 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSAcquisition of Medichem Manufacturing
27th Sep 20217:00 amRNSH1 Trading Update and Notice of Results
20th Aug 202111:47 amRNSIssue of Shares under Share Incentive Plan & TVR
23rd Jul 202112:08 pmRNSImplementation of Long Term Incentive Plan
22nd Jul 20215:35 pmRNSNotification of Major Holdings
21st Jul 20217:00 amRNSNotification of Major Holdings
20th Jul 20215:59 pmRNSDirector Dealing
19th Jul 20217:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.